Skip to Main Content

Paper Details

Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage.
Circulation
13
2022
Ca, Cardiac Damage, Cas9, HTNB, HTNB mutations, Human, Human induced pluripotent stem cells, Hypertension, Mutant Phosphodiesterase 3A, N, PDE3, PDE3A, PDE3A enzyme, Phosphodiesterase 3A, cAMP, cardiac damage, cardiac hypertrophy, cardiomyocytes, catecholamine, exon 13, exon 4, exon 4 and 13, heart failure, hypertension, hypertension with brachydactyly, induced pluripotent stem cell cardiomyocyte models, mRNA, patients, phospholamban, rat, rat models, rats, salt retention, stroke, vascular smooth muscle, wild
Author NameAffiliation
Norbert H??bnerMax-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC)
Norbert H??bner
Norbert H??bnerCharite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Norbert H??bnerMax-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC)
Norbert H??bner
Norbert H??bnerCharite-Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
  • 1 - 6

Datasets

Release 1.2